Clinical trials
Phase 2/3 Adenocarcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Unknown status | 3 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medical University of Lublin | 2 |
| Abbott | 1 |
| Affidea Nu-med Center of Oncological DIagnostics and Therapy | 1 |
| Astex Pharmaceuticals, Inc. | 1 |
| Dr. Gordon Buduhan | 1 |
| Eastern Hepatobiliary Surgery Hospital | 1 |
| Eurofarma Laboratorios S.A. | 1 |
| First Affiliated Hospital of Fujian Medical University | 1 |
| Guangzhou Medical University | 1 |
| Pierian Biosciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma | 12 |
| Prostatic Neoplasms | 3 |
| Digestive System Diseases | 2 |
| Esophageal Neoplasms | 2 |
| Neoplasms | 2 |
| Bile Duct Diseases | 1 |
| Biliary Tract Diseases | 1 |
| Carcinoma | 1 |
| Carcinoma, Hepatocellular | 1 |
| Cholangiocarcinoma | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.